Literature DB >> 9271001

Progesterone protects against lipid peroxidation following traumatic brain injury in rats.

R L Roof1, S W Hoffman, D G Stein.   

Abstract

The gonadal hormone, progesterone, has been shown to have neuroprotective effects in injured nervous system, including the severity of postinjury cerebral edema. Progesterone's attenuation of edema is accompanied by a sparing of neurons from secondary neuronal death and with improvements in cognitive outcome. In addition, we recently reported that postinjury blood-brain barrier (BBB) leakage, as measured by albumin immunostaining, was significantly lower in progesterone treated than in nontreated rats, supporting a possible protective action of progesterone on the BBB. Because lipid membrane peroxidation is a major contributor to BBB breakdown, we hypothesized that progesterone limits this free radical-induced damage. An antioxidant action, neuroprotective in itself, would also account for progesterone's effects on the BBB, edema, and cell survival after traumatic brain injury. To test progesterone's possible antiperoxidation effect, we compared brain levels of 8-isoprostaglandin F2 alpha (8-isoPGF2 alpha), a marker of lipid peroxidation, 24, 48, and 72 h after cortical contusion in male rats treated with either progesterone or the oil vehicle. The brains of progesterone treated rats contained approximately one-third of the 8-isoPGF2 alpha found in oil-treated rats. These data suggest progesterone has antioxidant effects and support its potential as a treatment for brain injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271001     DOI: 10.1007/bf02815156

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  82 in total

1.  Don't forget the "single chromosome polymorphism": a need for gender-stratification in pediatric patients?

Authors:  Ericka L Fink; Robert S B Clark
Journal:  Pediatr Crit Care Med       Date:  2004-03       Impact factor: 3.624

Review 2.  Antioxidant strategies in neurocritical care.

Authors:  Khalid A Hanafy; Magdy H Selim
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 3.  Progesterone and neuroprotection.

Authors:  Meharvan Singh; Chang Su
Journal:  Horm Behav       Date:  2012-06-23       Impact factor: 3.587

4.  Effect of phosphamidon on convulsive behavior and biochemical parameters: modulation by progesterone and 4'-chlorodiazepam in rats.

Authors:  Vikas Joshi; Tarun Arora; Ashish K Mehta; Amit K Sharma; Naveen Rathor; Kapil D Mehta; Prabha Mahajan; Pramod K Mediratta; Basu D Banerjee; Krishna K Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-25       Impact factor: 3.000

5.  Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex.

Authors:  M Singh
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 6.  Therapies targeting lipid peroxidation in traumatic brain injury.

Authors:  Tamil Selvan Anthonymuthu; Elizabeth Megan Kenny; Hülya Bayır
Journal:  Brain Res       Date:  2016-02-10       Impact factor: 3.252

7.  Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices.

Authors:  Claudia C Aguirre; Michel Baudry
Journal:  Eur J Neurosci       Date:  2009-01-17       Impact factor: 3.386

Review 8.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 9.  Estrogens and progesterone as neuroprotectants: what animal models teach us.

Authors:  Meharvan Singh; Nathalie Sumien; Cheryl Kyser; James W Simpkins
Journal:  Front Biosci       Date:  2008-01-01

10.  Reversal of propoxur-induced impairment of memory and oxidative stress by 4'-chlorodiazepam in rats.

Authors:  Kapil Dev Mehta; Gobind Rai Garg; Ashish K Mehta; Tarun Arora; Amit K Sharma; Naresh Khanna; Ashok K Tripathi; Krishna K Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.